World Health Organization WHO, Regional Office of Europe
2
всемирная организация здравоохранения (ВОЗ)
2
A. Rakotoarisoa, L. Randrianasolo, S. Tempia, et al.
1
Agustina R., Dartanto T., Sitompul R., et al.
1
and K.Seck
1
Arbo Sosa, A.H. et al.
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Bild und Sprache e.V.
1
Bioethics
1
Bulletin of the World Health Organization
1
Capps, B.
1
Center for Excellence in Disaster Management and Humanitarian Assistance
1
Centre Pasteur du Cameroun
1
Centro de Coordinación de Alertas y Emergencias Sanitarias
1
Charité Berlin
1
Chowell and Nishiura
1
Christa L Fischer Walker, Igor Rudan, Li Liu, Harish Nair, et al.
1
Clayton O. Onyango, Regina Njeru, Sidi Kazungu et al.
1
Corman, V.
1
D. Antognini, A. Combes, et al.
1
Department of Health, National Center for Health Promotion, National Center for Disease Prevention and Control
1
DGVS Paraguay
1
Dirección General de Vigilancia de la Salud (DGVS)
1
Direction de la conte lutte contre la maladie les épidémies et les pandémies
1
Direction de Lutte contre la Maladie, Ministère de la Santé Publique, République Démocratique du Congo
1
Directorate General of Health Services , Ministry of Health & Family Welfare, Government of India
1
Dr. S. Eyangoh et. al.
1
Dr. Vernet G
1
Dra. María Cristina Guillén
1
D’A. Richardson
1
D’Arcy Richardson, PATH, and Greg Pirio, Empower Communications
1
Eastern Mediterranean Region
1
ECDC (European Centre for Disease Prevention and Control)
1
Ethiopian Health and Nutrition Research Institute Public Health Emergency Management Centre
1
Eurosurveillance
1
FAO
1
Federal Ministry Of Health - Nigeria Centre for Disease Control
1
G. Pirio
1
GiZ Deutsche Gesellschaft für Internationale Zusammenarbeit
1
GOARN, FAO, et al.
1
Gobierno Bolivariano de Venezuela, et al.
1
Government of Nepal, Ministry of Health and Population
1
Governments of Guinea, Liberia, Sierra Leone
1
Harvey V. Fineberg
1
Hassane Sylla, A.
1
Hélène Fagherazzi-Pagel
1
Imperial College COVID-19 Response Team
1
International Federation of Red Cross and Red Crescent Societies
1
International Federation of Red Cross and Red Crescent Societies IFR
1
International Federation of Red Cross and Red Crescent Societies, Water and Sanitation Mission Assistant
1
ISARIC
1
Jean-Gilles, L.
1
Johanniter-Unfall-Hilfe e.V.
1
K. Lancaster
1
K4Health (Knowledge for Helath)
1
Keymanthri Moodley, Kate Hardie, Michael J Selgelid, et al.
1
M. Hegermann-Lindencrone, C. S. Brown, et al.
1
M.M. Bailey, D. Bickford et al.
1
Masumbuko ClaudeK, Underschultz J,Hawkes MT
1
MINISTERE DE LA SANTE REPUBLIQUE TOGOLAISE
1
Ministere de la Santé Publique
1
Ministerio da Saude, Brasilia
1
Ministerio de Salud de Peru
1
Ministerio de Salud Publica y Bienestar Social
1
Ministerio de Salud Pública y Bienestar Social
1
Ministerio de Salud Pública y Bienestar Social (MSPBS), Paraguay
1
Ministerio de Salud Pública y Bienestar Social Paraguay
1
Ministerio de salud pública y bienestar social, Paraguay todos y todas, et al.
1
Ministerio de Salud, Peru
1
Ministerio de sanidad - España
1
Ministère de la Santè Maroc
1
Ministère de la Santè Publique et de la Population Haiti
1
Ministère de la Santé Publique et de la Population
1
Ministry of Health and Social Services (MOHSS)
1
Ministry of Health Ghana
1
Ministry of Health Rwanda
1
Ministry of Health Rwanda, Biomedical Center Institute of HIV
1
Ministry of Health, Ghana, World Health Organizaiotn (WHO) and Ghana Health Service
1
Mme C. Owona
1
NADMO Ghana
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
NPJ
1
OMS, UNICEF. FAO
1
OPAS
1
Organisation de la Santé Mondiale, Bureau Regional de l'Afrique
1
Organisation mondiale de la Santé
1
Organisation mondiale de la Santé (WHO), Bureau Régional de l'Afrique
1
Organisation Mondiale de la Santé, Bureau régional de l'OMS pour l'Afrique
1
Organización Mundial de la Salud
1
Organização Mundial da Saùde
1
Páez, L.S.
1
Philippine Society for Microbiology and Infectious Diseases, Philippine College of Chest Physicians, Philippine Academy of Family Physicians
1
Prevent Project
1
Ramanathan, K.
1
Republica de Honduras
1
Reusken C. B. E. M., E. K. Broberg, B. Haagmans et al.
1
République de Cameroun
1
Rhodes, T.
1
Robert Koch-Institut
1
S. Brünink
1
S. Lees et al.
1
S. Novoa, B. Nieto et al.
1
SEGO, SAC Ecuador
1
Setzer Verlag
1
Steve Aldrich, et al.
1
Stop TB Partnership
1
T. Bleicker
1
TB online
1
The Dag Hammarskjöld Foundation and ReAct
1
The Lancet
1
TipDoc
1
Towards a Safer World
1
UN Children's Fund UNICEF
1
UNAIDS
1
UNICEF Madagascar
1
Unidad de vigilancia de la Salud, Gobierno de la répubica de Honduras
1
UNIECF
1
Universidad Central de Venezuela
1
University of Nottingham
1
USAID, StopTBPartnership
1
Viva Paraguqy, et al.
1
Western Pacific Region
1
WHO Country Office for Nepal
1
WHO Health Emergencies Programme in association with UN Clinic, Kathmandu
1
WHO South East Asia Regional Office
1
Woodhead M., F. Blasi, S. Ewig, et al.
1
World Health Organization ( WHO), Regional Office for South-East-Asia
1
World Health Organization, Regional Office for Europe
1
Worldometer
1
Xiaoxu Wu, Yongmei Lu, Sen Zhou et al.
1
Всемирная организация здравоохранения
1
Камкин Евгений Геннадьевич, Костенко Наталья Алексеевна et. al.
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...e in the care of critically ill patients – from hospital entry to hospital discharge.
The 2022 updated version includes new tools and adapted algorithms, checklists, memory aids for COVID-19 and influenza, and the latest clinical evidence regarding clinical management of SARI. It is intended to help clinicians care for SARI patients: from epidemiology of severe acute respiratory infections, screening and triage, infection prevention and control, monitoring of patients, laboratory diagnosis, principles of oxygen therapy and different types of ventilation (invasive and non-invasive), as well as antimicrobial and immunomodulator therapies, to ethical and quality of care assessments.
The first edition is availbel in Ukrainian and Russianmore
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...ry Infection (SARI) to estimate COVID-19 vaccine effectiveness (VE) in preventing SARI associated with laboratory-confirmed SARS-CoV-2 using existing SARI surveillance systems. The approach uses the test-negative design to evaluate VE; cases are SARI patients who tested positive for SARS-CoV-2, and controls are SARI patients who tested negative for SARS-CoV-2.more
The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise of public health and provides a framework to inform the exercise of the new essential functions. The th...ird section proposes a new integrated approach for implementing the EPHFs. The fourth section presents a new list of 11 EPHFs related to each stage of this integrated approach. Finally, in the last section, considerations are put forth to guide EPHF implementation as a means of strengthening the health sector.more
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vaccine hesitant respondents across Latin America in January 2021, we experimentally tested how fiv...e features of mass vaccination campaigns—the vaccine’s producer, efficacy, endorser, distributor, and current population uptake rate—shifted willingness to take a COVID-19 vaccine. We find that citizens preferred Western-produced vaccines, but were highly influenced by factual information about vaccine efficacy. Vaccine hesitant individuals were more responsive to vaccine messengers with medical expertise than political, religious, or media elite endorsements. Citizen trust in foreign governments, domestic leaders, and state institutions moderated the effects of the campaign features on vaccine acceptance. These findings can help inform the design of unfolding mass inoculation campaigns.more
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...o the practices of the global health community is required if we want to be better prepared for the future threats. This document provides guidance for laboratories on maximizing the impact of SARS-CoV-2 sequencing now and other emerging pathogens in the future.more
This third edition of the landscape analysis provides regional and country-specific data. This report illustrates the complexities in surveillance of influenza and other respiratory viruses and highlights differences in the countries’ preparedness capacities through charts, infographics, tables, a...nd brief narratives.more
BMJ Global Health2020;5:e002914. doi:10.1136/bmjgh-2020-002914
The evidence produced in mathematical models plays a key role in shaping policy decisions in pandemics. A key question is therefore how well pandemic models relate to their implementation contexts. Drawing on the cases of Ebola and in...fluenza, we map how sociological and anthropological research contributes in the modelling of pandemics to consider lessons for COVID-19. We show how models detach from their implementation contexts through their connections with global narratives of pandemic response, and how sociological and anthropological research can help to locate models differently. This potentiates multiple models of pandemic response attuned to their emerging situations in an iterative and adaptive science. We propose a more open approach to the modelling of pandemics which envisages the model as an intervention of deliberation in situations of evolving uncertainty. This challenges the ‘business-as-usual’ of evidence-based approaches in global health by accentuating all science, within and beyond pandemics, as ‘emergent’ and ‘adaptive’.more
Der Artikel "Händedesinfektion unter den Bedingungen der SARS-CoV-2-Pandemie" war am 4.5.2020 online vorab erschienen und ist nun in der regulären Ausgabe des Epidemiologischen Bulletins 19/2020 zu finden.
Bei vielen schwer erkrankten Menschen muss mit einer im Verhältnis zu anderen schweren ARE längeren Behandlung mit Beatmung/zusätzlichem Saürstoffbedarf gerechnet werden. Da weder eine Impfung noch eine spezifische Therapie derzeit zur Verfügung stehen, müssen alle Massnahmen darauf ausgericht...et sein, die Verbreitung der Erkrankung so gut wie möglich zu verlangsamen. Es gibt 3 Komponenten: A) Verhinderung der Ausbreitung durch Fallfindung und Absonderung von engen Kontaktpersonen, B) soziale Distanz schaffen und C) gezielter Schutz von vulnerablen Gruppen, die aktiviert und intensiviert werden müssen ent-sprechend der jeweils aktuellen Lagemore
Mund-Nasen-Bedeckung im öffentlichen Raum als weitere Komponente zur Reduktion der Übertragungen von COVID-19. Strategieergänzungen zu empfohlenen Schutzmaßnahmen und Zielen (3. Update) Das RKI empfiehlt ein generelles Tragen einer Mund-Nasen-Bedeckung (MNB) in bestimmten Situationen im öffentl...ichen Raum als einen weiteren Baustein, um Risikogruppen zu schützen und den Infektionsdruck und damit die Ausbreitungsgeschwindigkeit von COVID-19 in der Bevölkerung zu reduzieren. Diese Empfehlung beruht auf einer Neubewertung aufgrund der zunehmenden Evidenz, dass ein hoher Anteil von Übertragungen unbemerkt erfolgt, und zwar bereits vor dem Auftreten von Krankheitssymptomen. Ziel des im Epidemiologischen Bulletin 19/2020 veröffentlichten Artikels ist es, eine kurze Übersicht zum fachlichen Hintergrund der Empfehlung zu geben und zu erläutern, welche Dinge hierbei zu berücksichtigen sind.more
Obejtivo General:
Establecer las directrices de vigilancia epidemiológica y laboratorio de COVID-19
dentro del Sistema Nacional de Vigilancia, que permita detectar los casos en el país y
evaluar los riesgos para generar información epidemiológica de calidad, que oriente a la toma de decisi...ones.more
El presente documento de trabajo fue elaborado en el marco de una investigación bibliográfica participativa y la experiencia acumulada por los técnicos de las áreas involucradas en la respuesta a las Infecciones Respiratorias Agudas (IRA) .
El documento constituye una guía orientativa de trab...ajo, que debe ser ajustado y adaptado a los niveles operativos, para garantizar el cumplimiento de los objetivos, ya que la vigilancia de esta infección está construyéndose a medida que la OMS comparte la información recabada y analizada. Puede ser revisado parcial o totalmente en el caso que la situación epidemiológica lo amerite.more
The household transmission investigation is a case-ascertained prospective study of all identified household contacts of a laboratory confirmed 2019-nCoV infection (see 2.2 Study population). It is intended to provide rapid and early information on the clinical, epidemiological and virological chara...cteristics of 2019-nCoV.
There are three primary objectives of this household transmission study:
To better understand the extent of transmission within a household by estimating the secondary infection rate for household contacts at an individual level, and factors associated with any variation in the secondary infection risk.
To characterize secondary cases including the range of clinical presentation, risk factors for infection, and the extent and fraction of asymptomatic infections.
To characterize serologic response following confirmed 2019-nCoV infection (highly encouraged, but optional depending on laboratory capacity and resources)more
Há três objetivos preliminares desse estudo de transmissão doméstica: 1. Para compreender melhor a extensão da transmissão doméstica estimando a taxa de infecção secundária1 para contatos domésticos em uma maneira individual, e fatores associados com qualquer variação no risco secundár...io da infecção. 2. Para caraterizar casos secundários incluindo a escala da apresentação clínica, fatores de risco para a infecção, a extensão e a fração de infecções assintomáticas. 3. Para caraterizar a resposta sorológica que segue a infecção confirmada pelo 2019-nCoV (altamente incentivado, mas opcional dependendo da capacidade e dos recursos do laboratório).more
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-...eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.more